| Ident. | Authors (with country if any) | Title |
|---|
| 000090 (2020) |
Muneyoshi Futami [Japon] ; Keisuke Suzuki [Japon] ; Satomi Kato [Japon] ; Saori Ohmae [Japon] ; Yoshio Tahara [Japon] ; Masanori Nojima [Japon] ; Yoichi Imai [Japon] ; Takayuki Mimura [Japon] ; Yoshihiro Watanabe [Japon] ; Arinobu Tojo [Japon] | The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells. |
| 000191 (2020) |
Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon] | Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study. |
| 000719 (2019) |
Kazutoshi Ebisawa [Japon] ; Yosuke Masamoto [Japon] ; Junji Tokushige [Japon] ; Hiroshi Nishi [Japon] ; Kenjiro Honda [Japon] ; Munetoshi Hinata [Japon] ; Kazuhiro Toyama [Japon] ; Masaomi Nangaku [Japon] ; Mineo Kurokawa [Japon] | Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease. |
| 000B48 (2019) |
Tomoyuki Asano ; Shuzo Sato ; Makiko Yashiro Furuya ; Hiroshi Takahashi ; Akiko Shichishima-Nakamura ; Hiroshi Ohkawara ; Tatsuo Fujiwara ; Naohiko Gunji ; Choichiro Hashimoto ; Tomoyuki Momma ; Motonobu Saito ; Hiroshi Nakano ; Guy Watanabe ; Jumpei Temmoku ; Yuya Fujita ; Naoki Matsuoka ; Hiroko Kobayashi ; Hiroshi Watanabe ; Mariko Mouri [Japon] ; Fumi Mashiyama [Japon] ; Hiroko Sakuma [Japon] ; Hiromasa Ohira ; Masaaki Mori [Japon] ; Takayuki Ikezoe ; Kiyoshi Migita | Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation |
| 001141 (2018) |
Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon] | Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). |
| 001404 (2018) |
Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon] | Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study. |
| 001696 (2017) |
Yoshihide Asano [Japon] | Recent advances in the treatment of skin involvement in systemic sclerosis. |
| 001768 (2017) |
Takashi Matsuwaki [Japon] ; Kiseko Shionoya [Suède] ; Robert Ihnatko [Suède] ; Anna Eskilsson [Suède] ; Shigeru Kakuta [Japon] ; Sylvie Dufour [France] ; Markus Schwaninger [Allemagne] ; Ari Waisman [Allemagne] ; Werner Müller [Royaume-Uni] ; Emmanuel Pinteaux [Royaume-Uni] ; David Engblom [Suède] ; Anders Blomqvist [Suède] | Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses. |
| 001773 (2017) |
Sohtaro Mine [Japon] ; Tsunekazu Hishima [Japon] ; Akihiko Suganuma [Japon] ; Hitomi Fukumoto [Japon] ; Yuko Sato [Japon] ; Michiyo Kataoka [Japon] ; Tsuyoshi Sekizuka [Japon] ; Makoto Kuroda [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Masashi Fukayama [Japon] ; Harutaka Katano [Japon] | Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets. |
| 001A36 (2016) |
Eri Watanabe [Japon] ; Hitoshi Sugawara [Japon] ; Takeshi Yamashita [Japon] ; Akira Ishii [Japon] ; Aya Oda [Japon] ; Chihiro Terai [Japon] | Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review |
| 001C25 (2016) |
Yuko Kaneko [Japon] ; Tatsuya Atsumi [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon] | Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study). |
| 001D22 (2016) |
Kouki Nakamura [Japon] ; Yoshihide Asano [Japon] ; Takashi Taniguchi [Japon] ; Shun Minatsuki [Japon] ; Toshiro Inaba [Japon] ; Hisataka Maki [Japon] ; Masaru Hatano [Japon] ; Takashi Yamashita [Japon] ; Ryosuke Saigusa [Japon] ; Yohei Ichimura [Japon] ; Takehiro Takahashi [Japon] ; Tetsuo Toyama [Japon] ; Ayumi Yoshizaki [Japon] ; Tomomitsu Miyagaki [Japon] ; Makoto Sugaya [Japon] ; Shinichi Sato [Japon] | Serum levels of interleukin‐18‐binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis |
| 001E94 (2015) |
Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon] | Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. |
| 002066 (2015) |
Yoh Arita [Japon] ; Yoshikazu Nakaoka [Japon] ; Michio Otsuki [Japon] ; Kaori Higuchi [Japon] ; Takahiro Hashimoto-Kataoka [Japon] ; Taku Yasui [Japon] ; Takeshi Masaki [Japon] ; Tomohito Ohtani [Japon] ; Tadamitsu Kishimoto [Japon] ; Keiko Yamauchi-Takihara [Japon] ; Issei Komuro [Japon] ; Yasushi Sakata [Japon] | Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis. |
| 002257 (2015) |
Chak Sing Lau [Hong Kong] ; Faith Chia [Singapour] ; Andrew Harrison [Nouvelle-Zélande] ; Tsu-Yi Hsieh [Taïwan] ; Rahul Jain [Inde] ; Seung Min Jung [Corée du Sud] ; Mitsumasa Kishimoto [Japon] ; Ashok Kumar [Inde] ; Khai Pang Leong [Singapour] ; Zhanguo Li [République populaire de Chine] ; Juan Javier Lichauco [Philippines] ; Worawit Louthrenoo [Thaïlande] ; Shue-Fen Luo [Taïwan] ; Peter Nash [Australie] ; Chin Teck Ng [Singapour] ; Sung-Hwan Park [Corée du Sud] ; Bagus Putu Putra Suryana [Indonésie] ; Parawee Suwannalai [Thaïlande] ; Linda Kurniaty Wijaya [Indonésie] ; Kazuhiko Yamamoto [Japon] ; Yue Yang [République populaire de Chine] ; Swan Sim Yeap [Malaisie] | APLAR rheumatoid arthritis treatment recommendations |
| 002297 (2014) |
Saori Sakaue [Japon] ; Shuji Sumitomo [Japon] ; Kanae Kubo [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon] | Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis. |
| 002444 (2014) |
Manabu Araki [Japon] ; Takako Matsuoka ; Katsuichi Miyamoto ; Susumu Kusunoki ; Tomoko Okamoto ; Miho Murata ; Sachiko Miyake ; Toshimasa Aranami ; Takashi Yamamura | Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. |
| 002636 (2014) |
Manabu Araki [Japon] ; Takako Matsuoka [Japon] ; Katsuichi Miyamoto [Japon] ; Susumu Kusunoki [Japon] ; Tomoko Okamoto [Japon] ; Miho Murata [Japon] ; Sachiko Miyake [Japon] ; Toshimasa Aranami [Japon] ; Takashi Yamamura [Japon] | Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study |
| 002698 (2013) |
Mihoko Shibuya [Japon] ; Keishi Fujio ; Kaoru Morita ; Hiroaki Harada ; Hiroko Kanda ; Kazuhiko Yamamoto | Successful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis. |
| 002769 (2013) |
Yukinori Okada [États-Unis] ; Di Wu [États-Unis, Australie] ; Gosia Trynka [États-Unis] ; Towfique Raj [États-Unis] ; Chikashi Terao [Japon] ; Katsunori Ikari [Japon] ; Yuta Kochi [Japon] ; Koichiro Ohmura [Japon] ; Akari Suzuki [Japon] ; Shinji Yoshida [Japon] ; Robert R. Graham [États-Unis] ; Arun Manoharan [États-Unis] ; Ward Ortmann [États-Unis] ; Tushar Bhangale [États-Unis] ; Joshua C. Denny [États-Unis] ; Robert J. Carroll [États-Unis] ; Anne E. Eyler [États-Unis] ; Jeffrey D. Greenberg [États-Unis] ; Joel M. Kremer [États-Unis] ; Dimitrios A. Pappas [États-Unis] ; Lei Jiang [République populaire de Chine] ; Jian Yin [République populaire de Chine] ; Lingying Ye [République populaire de Chine] ; Ding-Feng Su [République populaire de Chine] ; Jian Yang [Australie] ; Gang Xie [Canada] ; Ed Keystone [Canada] ; Harm-Jan Westra [Pays-Bas] ; T Nu Esko [Estonie, États-Unis] ; Andres Metspalu [Estonie] ; Xuezhong Zhou [République populaire de Chine] ; Namrata Gupta [États-Unis] ; Daniel Mirel [États-Unis] ; Eli A. Stahl [États-Unis] ; Dorothée Diogo [États-Unis] ; Jing Cui [États-Unis] ; Katherine Liao [États-Unis] ; Michael H. Guo [États-Unis] ; Keiko Myouzen [Japon] ; Takahisa Kawaguchi [Japon] ; Marieke J. H. Coenen [Pays-Bas] ; Piet L. C. M. Van Riel [Pays-Bas] ; Mart A. F. J. Van De Laar [Pays-Bas] ; Henk-Jan Guchelaar [Pays-Bas] ; Tom W. J. Huizinga [Pays-Bas] ; Philippe Dieudé [France] ; Xavier Mariette [France] ; S. Louis Bridges [États-Unis] ; Alexandra Zhernakova [Pays-Bas] ; Rene E. M. Toes [Pays-Bas] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Corinne Miceli-Richard [France] ; So-Young Bang [Corée du Sud] ; Hye-Soon Lee [Corée du Sud] ; Javier Martin [Espagne] ; Miguel A. Gonzalez-Gay [Espagne] ; Luis Rodriguez-Rodriguez [Espagne] ; Solbritt Rantap Dahlqvist [Suède] ; Lisbeth Rlestig [Suède] ; Hyon K. Choi [États-Unis] ; Yoichiro Kamatani [France] ; Pilar Galan [France] ; Mark Lathrop [Canada] ; Steve Eyre [Royaume-Uni] ; John Bowes [Royaume-Uni] ; Anne Barton [Royaume-Uni] ; Niek De Vries [Pays-Bas] ; Larry W. Moreland [États-Unis] ; Lindsey A. Criswell [États-Unis] ; Elizabeth W. Karlson [États-Unis] ; Atsuo Taniguchi [Japon] ; Ryo Yamada [Japon] ; Michiaki Kubo [Japon] ; Jun S. Liu [États-Unis] ; Sang-Cheol Bae [Corée du Sud] ; Jane Worthington [Royaume-Uni] ; Leonid Padyukov [Suède] ; Lars Klareskog [Suède] ; Peter K. Gregersen [États-Unis] ; Soumya Raychaudhuri [États-Unis, Royaume-Uni] ; Barbara E. Stranger [États-Unis] ; Philip L. De Jager [États-Unis] ; Lude Franke [Pays-Bas] ; Peter M. Visscher [Australie] ; Matthew A. Brown [Australie] ; Hisashi Yamanaka [Japon] ; Tsuneyo Mimori [Japon] ; Atsushi Takahashi [Japon] ; Huji Xu [République populaire de Chine] ; Timothy W. Behrens [États-Unis] ; Katherine A. Siminovitch [Canada] ; Shigeki Momohara [Japon] ; Fumihiko Matsuda [Japon] ; Kazuhiko Yamamoto [Japon] ; Robert M. Plenge [États-Unis] | Genetics of rheumatoid arthritis contributes to biology and drug discovery |
| 002867 (2013) |
Tsutomu Takeuchi [Japon] ; Masayoshi Harigai [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Naoki Ishiguro [Japon] ; Kazuhiko Yamamoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Takao Koike [Japon] ; Minoru Kanazawa [Japon] ; Takuya Oba [Japon] ; Toru Yoshinari [Japon] ; Daniel Baker [États-Unis] | Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks |
